skip to Main Content

Mir-2a-5p Regulates Gemcitabine Chemosensitivity by Targeting RRM2 in Pancreatic Cancer Cells and Serves as a Prdictor for Gemcitabine Base Chemotherapy

Newsfeed image, light gray text on dark gray background
Ribonucleotide reductase subunit M2 ( RRM2 ) acts as an important gemcitabine resistance-related gene in pancreatic cancer (PC). Here, we aimed to investigate the potential microRNA which regulates gemcitabine chemosensitivity by targeting RRM2 and explore the clinical significance of candidate miRNA in PC. 

Read more . . . 

Back To Top